| This article has been cited by |
| 1 | Ovarian Serous Carcinoma: A Retrospective Study of Clinicopathological Findings and Postchemotherapy Changes | |
| Navatha Vangala,Shantveer G Uppin,Megha S Uppin,Tara Roshni Paul,G Sadashivudu |
| Indian Journal of Medical and Paediatric Oncology.2020;41(05)663 |
| [DOI] |
|
| 2 | Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma | |
| Sumire Sugimoto,Tomoko Uchiyama,Naoki Kawahara,Chiho Ohbayashi,Hiroshi Kobayashi |
| International Journal of Gynecological Pathology.2021;40(5)419 |
| [DOI] |
|
| 3 | What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors | |
| Antonio De Leo,Donatella Santini,Claudio Ceccarelli,Giacomo Santandrea,Andrea Palicelli,Giorgia Acquaviva,Federico Chiarucci,Francesca Rosini,Gloria Ravegnini,Annalisa Pession,Daniela Turchetti,Claudio Zamagni,Anna Myriam Perrone,Pierandrea De Iaco,Giovanni Tallini,Dario de Biase |
| Diagnostics.2021;11(4)697 |
| [DOI] |
|
| 4 | Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women | |
| Tsutomu Ida,Hiroyuki Fujiwara,Takahiro Kiriu,Yoshimi Taniguchi,Akira Kohyama |
| Journal of Gynecologic Oncology.2019;30(6)697 |
| [DOI] |
|
| 5 | HISTOPATHOLOGICAL CHANGES OF FALLOPIAN TUBE IN UTERINE MALIGNANCIES | |
| Arsha V,Lillykutty Pothen,Sankar S |
| Journal of Evolution of Medical and Dental Sciences.2018;7(14)1786 |
| [DOI] |
|
| 6 | The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma | |
| Priya Singh,Vikrant Kaushal,Bhavana Rai,Arvind Rajwanshi,Nalini Gupta,Pranab Dey,Rashi Garg,Manish Rohilla,Vanita Suri,Sushmita Ghoshal,Radhika Srinivasan |
| Histopathology.2018;72(4)619 |
| [DOI] |
|
| 7 | Progestin Significantly Inhibits Carcinogenesis in the Mogp-TAg Transgenic Mouse Model of Fallopian Tube Cancer | |
| Omar L. Nelson,Rebecca Rosales,Jane M. Turbov,Larry G. Thaete,J. Mark Cline,Gustavo C. Rodriguez |
| Cancer Prevention Research.2022;15(2)75 |
| [DOI] |
|
| 8 | Pathogenesis and heterogeneity of ovarian cancer | |
| Paul T. Kroeger,Ronny Drapkin |
| Current Opinion in Obstetrics & Gynecology.2017;29(1)26 |
| [DOI] |
|
| 9 | The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer | |
| Hiroshi Kobayashi,Kana Iwai,Emiko Niiro,Sachiko Morioka,Yuki Yamada,Kenji Ogawa,Naoki Kawahara |
| Biomedical Reports.2017;7(3)209 |
| [DOI] |
|
| 10 | Cancer Risk-Reducing Opportunities in Gynecologic Surgery | |
| Carolyn Piszczek,Jun Ma,Claire H. Gould,Paul Tseng |
| Journal of Minimally Invasive Gynecology.2018;25(7)1179 |
| [DOI] |
|
| 11 | Serous Tubal Carcinogenesis: The Recent Concept of Origin of Ovarian, Primary Peritoneal and Fallopian Tube High-Grade Serous Carcinoma | |
| Tushar Kar,Asaranti Kar,Ipsita Dhal,Sasmita Panda,Priyadarshini Biswal,Bhagyalaxmi Nayak,Niranjan Rout,Sagarika Samantray |
| The Journal of Obstetrics and Gynecology of India.2017;67(6)432 |
| [DOI] |
|
| 12 | Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma | |
| Rosie T. Jiang,Anna Yemelyanova,Deyin Xing,Ravi K. Anchoori,Jun Hamazaki,Shigeo Murata,Jeffrey D. Seidman,Tian-Li Wang,Richard B. S. Roden |
| Journal of Ovarian Research.2017;10(1)432 |
| [DOI] |
|
| 13 | Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis | |
| Hiroshi Kobayashi,Kenji Ogawa,Naoki Kawahara,Kana Iwai,Emiko Niiro,Sachiko Morioka,Yuki Yamada |
| Free Radical Research.2017;51(9-10)755 |
| [DOI] |
|
